Search results
Found 9444 matches for
We are delighted to announce that Pernille Søgaard, a 2nd year DPhil student at the Kennedy Institute, NDORMS has received an award for best presentation at the 32nd Winter School on Proteinases and Their Inhibitors held in Tiers an Rosengarten, Italy earlier this month.
Cellular roadmap reveals new paths to treating inflammatory bowel disease
Research
22 October 2024
In a world first, researchers at the Kennedy Institute, Oxford have mapped the cellular dynamics following treatment with the most commonly used advanced therapy in autoimmune diseases. They have discovered why some patients benefit from this therapy while others do not, potentially paving the way for new therapies.
The role of mechanical forces in T cell activation
Research
9 October 2024
A perspectives piece published in the Proceedings of the National Academy of Sciences (PNAS) sheds light on the importance of mechanical forces in the early activation of T cells, a critical part of the immune response.
Lab to Clinic Conference Celebrates 25 Years of Biological Therapies
23 September 2024
This August, the annual ‘From the Laboratory to the Clinic’ conference celebrated 25 years since the first biological therapies were approved for rheumatoid arthritis. The conference brings together a global audience of clinicians and academic and industrial scientists, facilitating discussions to bring novel treatments from bench to bedside.
Dr Kate Coldwell awarded Daphne Jackson Fellowship to study links between liver disease and gut bacteria
Awards
17 September 2024
Dr Kate Coldwell has joined the Oxford Centre for Microbiome Studies at the Kennedy Institute to study the links between liver disease and gut bacteria, having been awarded the Daphne Jackson Fellowship, co-funded by the Kennedy Trust for Rheumatology Research (KTRR) and the Medical Research Council.
Kennedy scientists honoured with Royal Society Medal
Awards Department
16 September 2024
Professor Sir Ravinder Maini and Professor Sir Marc Feldmann have jointly received The Royal Society’s Royal Medal (Applied) for inventing anti-TNF therapy to treat rheumatoid arthritis (RA), bringing it from bench to bedside in one of the biggest success stories of modern medicine.
Kennedy Institute retreat 2024 - a whirlwind of ideas and inspiration!
Department
9 September 2024
The Kennedy Institute retreat took place in July 2024 at the Saïd Business School, Oxford. Over two jam-packed days, attendees met new colleagues, learned about scientific advances and of course, had fun!
New microscopy method can pinpoint molecular interactions in cell membranes
21 August 2024
A new microscopy technique, developed by researchers at the Kennedy Institute, enables detailed analysis of molecular interactions in live cell membranes, overcoming previous limitations in sensitivity and accessibility.
CRUK funding will help develop new targets for ovarian cancer
Funding Research
21 August 2024
Irina Udalova has received funding from Cancer Research UK (CRUK) to study the diverse role of neutrophils in ovarian cancer.
Celebrating two new professorships at the Kennedy Institute
Department
25 July 2024
The Kennedy Institute at the University of Oxford recently hosted a dinner to celebrate and thank the Kennedy Trust for Rheumatology Research for its generous support and the endowment of two new professorships in translational medicine at the Institute.
Adrien Hallou joins Franco-British Young Leaders Programme
General
9 July 2024
The Franco-British Council has announced Dr. Adrien Hallou as one of its 20 new Young Leaders for 2024.
New network aims to bring together microbiome researchers across Oxford
4 June 2024
The Oxford Microbiome Network (OMiN) aims to facilitate collaborations, knowledge sharing, and access to resources for microbiome researchers across Oxford. OMiN is co-led by researchers in the Kennedy Institute of Rheumatology and the Department of Biology. The network officially launched on 20th May 2024 with an event at Keble College.
The Kennedy Institute welcomes Distinguished Investigator Dr Alan Sher
Department
4 June 2024
Alan has spent two months at the Kennedy Institute as a guest of Professor Dame Fiona Powrie. During his visit he has spent his time collaborating with researchers at the Kennedy and other departments in the University, and mentoring young investigators on their career development.
Oxford researchers contribute to report on the future of healthcare
General
23 May 2024
Prof. Michael Dustin was one of 17 researchers from across Oxford's Medical Sciences and Maths, Physics and Life Sciences Divisions that have contributed to a new report on the future of healthcare, compiled by Citi Global Perspectives & Solutions (Citi GPS).
NDORMS researchers awarded Associate Professor title
Awards
9 May 2024
The University of Oxford has awarded the title of Associate Professor to Calliope Dendrou and Siim Pauklin.
Kennedy DPhil selected for 2024 Schmidt Science Fellow program
Awards Department
7 May 2024
Dr Ashwin Jainarayanan has been selected to become a 2024 Schmidt Science Fellow – an honour bestowed on only 32 exceptional early career researchers worldwide.
British Heart Foundation Programme grant will explore the molecular immunology of heart and vessel disease
23 April 2024
A new programme of research led by Professor Claudia Monaco and funded by the British Heart Foundation aims to unpick the inflammatory processes behind cardiovascular disease so that immune-targeted therapies may be developed in future.
Connects-UK launches to foster scientific collaborations between EU and UK researchers in a post-Brexit era
General Research
10 April 2024
Connects-UK, a new pan-European network dedicated to advancing scientific collaborations between researchers in the European Union (EU) and the United Kingdom (UK), was officially launched at an event in London yesterday. The network, led by a diaspora of EU researchers working in the UK, seeks to bridge the gap created by Brexit and ensure that collaboration, innovative research, funding, and knowledge exchange continue to thrive in the post-Brexit era.
New study reveals how T cells gain and maintain tolerance to gut bacteria
Research
3 April 2024
The immune system in the intestine maintains a careful balance, tolerating our long-term resident (commensal) gut bacteria while defending against invading pathogens. Under certain circumstances, dysregulation of our intestinal immune response to commensal and pathogenic microbes can drive inflammatory disease.
PD-1 gets an “A” for team-work
Research
8 March 2024
A new understanding of the PD-1 axis (programmed death cell) could help shape ongoing efforts to improve treatments for cancer and autoimmune diseases.
Professor Irina Udalova appointed to the MRC’s Infections and Immunity Board
Department
1 March 2024
The Medical Research Council’s Infections and Immunity Board (IIB) funds research into infectious human disease and disorders of the human immune system.